This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The Second People's Hospital of Shenzhen (Shenzhen Institute of Geriatrics). Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Liuyang Pu: Innovator in Pharmaceutical Chemistry
Introduction
Liuyang Pu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of structural analogs of natural products.
Latest Patents
Liuyang Pu holds a patent for a "Structural analog of Cyclotheonellazole A, and synthetic method therefor and application method thereof." This patent describes a compound with a specific structure that includes a pharmaceutically acceptable salt. The invention utilizes a classical reverse synthesis analysis to modify the structure while maintaining the integrity of the natural product's mother nucleus. The resulting structural analog demonstrates excellent protease inhibitory activity, indicating strong potential applications in the pharmaceutical industry.
Career Highlights
Liuyang Pu is affiliated with the Second People's Hospital of Shenzhen, specifically within the Shenzhen Institute of Geriatrics. His work focuses on developing innovative solutions that can enhance therapeutic options in medicine.
Collaborations
Liuyang Pu collaborates with notable colleagues, including Shengquan Hu and Zhiyue Li. Their combined expertise contributes to advancing research in their respective fields.
Conclusion
Liuyang Pu's innovative work in pharmaceutical chemistry exemplifies the impact of structural modifications on drug development. His contributions are paving the way for future advancements in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile